(TARS) Tarsus Pharmaceuticals - Performance 49.9% in 12m
Compare TARS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
49.30%
#16 in Group
Rel. Strength
90.87%
#730 in Universe
Total Return 12m
49.92%
#19 in Group
Total Return 5y
139.31%
#13 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -4.64%
16th Percentile in Group
12m Total Return: TARS (49.9%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: TARS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TARS
Total Return (including Dividends) | TARS | XLV | S&P 500 |
---|---|---|---|
1 Month | 6.67% | -7.37% | -5.89% |
3 Months | 5.37% | -4.55% | -12.45% |
12 Months | 49.92% | -0.54% | 6.72% |
5 Years | 139.31% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | TARS | XLV | S&P 500 |
1 Month | -64.8% | -82.6% | -74.5% |
3 Months | -27.3% | -37.8% | -88.2% |
12 Months | 73.4% | -1.6% | 66.1% |
5 Years | 20.7% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #15 | 15.2% | 13.3% |
3 Month | #32 | 10.4% | 20.4% |
12 Month | #19 | 50.7% | 40.5% |
5 Years | #12 | 77.7% | 48.0% |
FAQs
Does TARS Tarsus Pharmaceuticals outperforms the market?
Yes,
over the last 12 months TARS made 49.92%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months TARS made 5.37%, while XLV made -4.55%.
Over the last 3 months TARS made 5.37%, while XLV made -4.55%.
Performance Comparison TARS vs Indeces and Sectors
TARS vs. Indices TARS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.48% | 12.6% | 43.9% | 43.2% |
US NASDAQ 100 | QQQ | 8.34% | 13.0% | 44.4% | 44.4% |
US Dow Jones Industrial 30 | DIA | 8.65% | 12.5% | 43.3% | 44.6% |
German DAX 40 | DAX | 2.12% | 16.1% | 26.8% | 31.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.77% | 14.2% | 41.6% | 44.0% |
Hongkong Hang Seng | HSI | 3.19% | 16.5% | 42.4% | 33.7% |
India NIFTY 50 | INDA | 3.11% | 1.90% | 41.4% | 46.9% |
Brasil Bovespa | EWZ | 3.92% | 11.8% | 40.9% | 59.4% |
TARS vs. Sectors TARS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.23% | 12.3% | 35.1% | 36.4% |
Consumer Discretionary | XLY | 8.35% | 10.6% | 41.1% | 40.7% |
Consumer Staples | XLP | 4.18% | 3.47% | 33.7% | 36.0% |
Energy | XLE | 2.76% | 16.8% | 42.8% | 60.2% |
Financial | XLF | 6.11% | 11.2% | 35.8% | 31.0% |
Health Care | XLV | 7.08% | 14.0% | 45.3% | 50.5% |
Industrial | XLI | 6.36% | 11.4% | 43.8% | 44.6% |
Materials | XLB | 5.76% | 13.3% | 51.0% | 57.5% |
Real Estate | XLRE | 2.14% | 9.56% | 42.5% | 32.8% |
Technology | XLK | 8.84% | 15.6% | 50.7% | 51.1% |
Utilities | XLU | 4.17% | 7.09% | 38.1% | 25.6% |
Aerospace & Defense | XAR | 5.79% | 6.63% | 34.1% | 25.8% |
Biotech | XBI | 3.92% | 18.6% | 58.4% | 58.8% |
Homebuilder | XHB | 6.53% | 13.5% | 61.8% | 59.0% |
Retail | XRT | 5.78% | 8.78% | 48.5% | 54.3% |